May 24, 2010Food and Drug Administration10903 New Hampshire AveSilver Spring, MD 20993-0002Attention: Dr. Margaret Hamburg, MD, Director, FDASubject: FDA Center for Devices and Radiological Health
clear” Wrongly Issued on Brain Tumor/Cell Phone Use
Dear Dr. Hamburg,The newly released INTERPHONE study has reported a clear increase in risk of glioma on thesame side of the head where a cell phone was used for more than 10 years. The INTERPHONEreport now confirms what many experts have warned
that regular use of a cell phone by adultscan significantly increase the risk of glioma by 40% with 1640 hours or more of use (and 96%with ipsilateral use). Tumors were more likely to occur on the side of the head most used for calling.
And yet, the FDA consumer advisory posted this week has issued what amounts to an “all clear”with the headline “
No Evidence Linking Cell Phone Use to Risk of Brain Tumors
FDAs dismissal of cell phone risks is unwarranted and counter to the evidence within theINTERPHONE study, its two appendices, and with opinions from the principal author, Dr.Elizabeth Cardis of CREAL (and formerly of IARC).To make the situation even more serious, there is emerging evidence that the risks of cell phoneuse by children is significantly greater than for adults. It is irresponsible for the FDA to ignorethis evidence. The credibility of the FDA is certainly at stake as the evidence of risk from cell phones grows with each new study.The FDAs role is protect consumers from risks of disease even when some questions remain asto the magnitude of that risk. We ask the following questions.
• Who told the FDAs Communications branch to issue an “all clear” on cell phone
On what new evidence of safety of cell phones did the FDA Center for Devices and Radiological Health change its mind and decide it was time to tell the public that there isno risk?